Search

Intratympanic treatments for subjective idiopathic tinnitus

Direct application of medication into the ear is long established, going back as far as written records. In the modern era, greater understanding of aural anatomy revealed that drugs instilled in the middle ear could potentially diffuse into the cochlea...

Screening for hearing loss in primary care

Hearing impairment is one physical disability that is increasing in prevalence in society in general, and in older adults in particular. Approximately 34 to 36 million Americans report suffering from some degree of hearing impairment with the number rising to...

The role of metrics in studies of hearing and cognition

Introduction When perceiving sounds in real-world listening environments, older adults encounter several sources of degradation that can interfere with the perceptual process (Figure 1). Target signals (i.e. the sounds that a listener wants to focus on) have specific acoustic characteristics...

A cognitive therapy programme for hearing impairment: reducing avoidance and mental distress

Cognitive behavioural therapy (CBT), a psychotherapeutic treatment method, is most commonly used to treat anxiety and depression. Newly published results from a controlled, clinical study demonstrate that an adapted CBT programme is useful for several common challenges in aural rehabilitation;...

The European TINNET COST Action BM1306

Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...

Out of Africa: Audiovannah audiology clinic in Zimbabwe

Audiovannah reception area. In 2015 two Danish audiologists, Jenny Pedersen and Nicolai Pedersen, relocated to Zimbabwe and opened a full service audiology clinic (Audiovannah) in the capital city of Harare. The focus has been to give back as much as...

What’s new in genetic testing for hearing impairment?

Often the first question following the diagnosis of a hearing loss is ‘why?’ In this article Ali Danesh explores the advances made in uncovering ‘why’ from a genetics perspective. Ali describes the panel of genetic tests now commercially available to...

A place for everything and everything in its place: the practicalities of randomised clinical trials

Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...

Central auditory changes in SNHL

Robert Harrison discusses some of the most obvious ways in which cochlear hearing loss has central consequences. It is convenient to classify hearing loss according to the most obvious site of lesion, for example, conductive, cochlear, retro-cochlear, or central hearing...

Human immunodeficiency virus and hearing impairment

With an estimated 36.7 million individuals living with HIV / AIDS and literature reporting that these conditions contribute to hearing loss, it is surprising that more focus and resources are not employed to tackle this major hearing health concern. Yolandé...

TEN testing in paediatric patients

Threshold equalising noise (TEN) testing is used to identify dead regions (DRs) of the cochlear. Alexandra Lusty considers the challenges of using the TEN test in the paediatric population as well as the importance of identifying DRs. Diagnosing dead regions...

Hearing aids 2019: today’s technology

High-end or basic hearing aids: does the technology level make a difference? Catherine Palmer shares the current evidence base and suggests where hearing healthcare professionals can make the most impact. The most common complaint from individuals with mild-to-moderately severe hearing...